April 30 (Reuters) - European chemicals maker DSM-Firmenich DSFIR.AS on Wednesday reported adjusted first-quarter core profit slightly below market expectations, adding its annual strategic plan is nevertheless "progressing well".
The group's adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) came in at 650 million euros ($739.18 million), just short of analysts' forecast of 655 million euros in a company-provided consensus.
The company, born out of the 2023 merger of Netherlands-based DSM and Switzerland-based Firmenich, said the adjusted core profit result included an 85 million euro temporary positive price effect caused by supply disruption in the vitamin market.
($1 = 0.8794 euros)
(Reporting by Alberto Chiumento and Dimitri Rhodes in Gdansk; Editing by Christopher Cushing)
((Alberto.chiumento@thomsonreuters.com))